News & HighlightsNews
Never too much of a good thing
Changing levels of a single protein can produce many different outcomes An ongoing scientific argument surrounds the Wnt protein: Different research groups say that Wnt proteins are involved in cell differentiation, proliferation, fate determination, stem cell self-renewal and cancer. But which g...
Single stressful events bring about gradual change in brain structure
Commuting is never fun, and is almost always stressful, in part because we often have no control over what happens to us. But everyday we get in our car, or board the train or bus, and make our way to work, having become accustomed to this stress, not realizing that this stress may have a measura...
Protein destruction helps plants enter a different life stage
As a seed awakens and begins to sprout, it must make a decision: does it have everything it needs to grow, or should it wait for better conditions? The choice rests on the presence or absence of one protein, ABI3, and new research from the laboratory of Nam-Hai Chua, Ph.D., at Rockefeller Univers...
Size doesn't matter
Rockefeller scientists show that microRNAs play an essential role in the development of the fruit fly In a story reminiscent of David and Goliath, new research from Rockefeller University shows that sometimes the smallest molecules can be the most powerful. In the July 1 issue of Cell, Ulrike Gau...
Lisa Danzig named Rockefeller University's chief investment officer
Lisa Danzig, director of investments at Rockefeller University, has been appointed vice president and chief investment officer effective July 1, President Paul Nurse has announced. Danzig, who joined the university’s Office of Investments in December 2000, will assume responsibility for managing ...
Rockefeller University vaccine researchers selected for grant from Foundation for NIH
A team of researchers led by Rockefeller University immunologist Ralph M. Steinman, M.D., has been selected for a grant offer from the Foundation for the NIH (FNIH) of $14 million to support the design of novel vaccines that stimulate multiple components of the body’s immune response, including t...
David Rockefeller pledges $100 million to Rockefeller University
Largest gift in University's history will support innovative science, graduate program New York, NY, June 9, 2005 — Paul Nurse, Ph.D., president of The Rockefeller University, announced today that David Rockefeller, honorary chairman and life trustee of the University's Board of Trustees, has ple...
Researchers create infectious hepatitis C virus in a test tube
Method enables scientists to study all stages of virus' life cycle A team of researchers led by scientists at The Rockefeller University has produced for the first time an infectious form of the hepatitis C virus (HCV) in laboratory cultures of human cells. The finding, reported in the June 9 iss...
Worming our way into the brain
Rockefeller scientists find that studying glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases. The key to understanding our brains may lie within a one-millimeter long worm, new research from Rockefeller University indicates. Reporting in the June is...
Rockefeller University scientist elected fellow of Royal Society
David Gadsby, Ph.D., professor and head of the Laboratory of Cardiac and Membrane Physiology at the Rockefeller University, was elected a fellow of the Royal Society today for his research into how ion transporters function, and specifically for furthering our understanding of the origins of cyst...
View
View